Joint (NASDAQ:JYNT) has been assigned a $21.00 target price by investment analysts at DA Davidson in a research report issued on Thursday, TipRanks reports. The brokerage currently has a “buy” rating on the stock. DA Davidson’s price target would suggest a potential upside of 30.43% from the stock’s previous close.

Several other equities analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Joint from a “hold” rating to a “strong-buy” rating and set a $22.00 target price for the company in a research note on Tuesday, May 14th. TheStreet upgraded shares of Joint from a “d” rating to a “b” rating in a research note on Friday, April 26th. Lake Street Capital boosted their target price on shares of Joint to $20.00 and gave the company a “buy” rating in a research note on Friday, March 8th. Maxim Group reissued a “buy” rating and issued a $18.00 price target (up previously from $11.00) on shares of Joint in a report on Friday, March 8th. Finally, ValuEngine raised shares of Joint from a “buy” rating to a “strong-buy” rating in a report on Wednesday, February 20th. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $18.60.

Shares of JYNT traded down $1.36 during trading hours on Thursday, hitting $16.10. The stock had a trading volume of 13,661 shares, compared to its average volume of 174,393. The company has a debt-to-equity ratio of 4.38, a current ratio of 1.00 and a quick ratio of 1.00. Joint has a fifty-two week low of $6.51 and a fifty-two week high of $19.81. The stock has a market cap of $240.26 million, a P/E ratio of 402.50, a P/E/G ratio of 7.76 and a beta of 0.86.

Joint (NASDAQ:JYNT) last posted its earnings results on Thursday, May 9th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.06. Joint had a net margin of 4.50% and a return on equity of 109.02%. The firm had revenue of $10.68 million during the quarter, compared to analysts’ expectations of $8.90 million. Equities analysts expect that Joint will post 0.22 EPS for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc increased its holdings in Joint by 7.0% in the 3rd quarter. Vanguard Group Inc now owns 276,974 shares of the company’s stock worth $2,368,000 after acquiring an additional 18,099 shares in the last quarter. Nantahala Capital Management LLC increased its holdings in Joint by 10.1% in the 4th quarter. Nantahala Capital Management LLC now owns 1,128,693 shares of the company’s stock worth $9,391,000 after acquiring an additional 103,972 shares in the last quarter. Vanguard Group Inc. increased its holdings in Joint by 7.0% in the 3rd quarter. Vanguard Group Inc. now owns 276,974 shares of the company’s stock worth $2,368,000 after acquiring an additional 18,099 shares in the last quarter. Redmond Asset Management LLC increased its holdings in Joint by 3.0% in the 1st quarter. Redmond Asset Management LLC now owns 53,285 shares of the company’s stock worth $839,000 after acquiring an additional 1,535 shares in the last quarter. Finally, Acadian Asset Management LLC increased its holdings in Joint by 7.2% in the 4th quarter. Acadian Asset Management LLC now owns 190,702 shares of the company’s stock worth $1,585,000 after acquiring an additional 12,859 shares in the last quarter. 47.76% of the stock is owned by institutional investors.

About Joint

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.

See Also: How to Profit and Limit Losses With Stop Orders

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.